Abdm
It is a surprised for a well research poster such as yourself to think that ANP is giving away the patents/licenses of ATL1102 for free.
Obviously placed no value in the cost needed for clinical trials, which is the main activity/concern as a Biotech before the exit point to a big Pharma in Phase III.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.9¢ |
Change
-0.001(5.56%) |
Mkt cap ! $9.243M | |||
| Open | High | Low | Value | Volume |
| 0.9¢ | 0.9¢ | 0.9¢ | $1.318K | 151.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 24 | 7776804 | 0.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.9¢ | 1487416 | 6 |
View Market Depth
| Last trade - 14.09pm 17/07/2025 (20 minute delay) ? |
| PER (ASX) Chart |